Evidence map›Paper›PMID 33227279›Full record

ArticleGastroenterology2021

Fusobacteriumnucleatum Adheres to Clostridioides difficile via the RadD Adhesin to Enhance Biofilm Formation in Intestinal Mucus.

Melinda A Engevik, Heather A Danhof, Jennifer Auchtung, Bradley T Endres, Wenly Ruan, Eugénie Bassères, Amy C Engevik, Qinglong Wu, Maribeth Nicholson, Ruth Ann Luna and 9 more

Open access · greenAbstract read
In one paragraph

Article in Gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
1.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 105 citations in OpenAlex.

  1. The role of adhesins ofGut microbes · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. RadD fromeLife · 2026
    Article
  8. Review
  9. Pathogenic Roles ofPathogens (Basel, Switzerland) · 2026
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Microorganisms · 2026
    Article
  15. Article
  16. Review
  17. Measuring C. difficile Adhesion to Mucosal Surfaces.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  18. Reprogramming of pathogenic strategies inFrontiers in cellular and infection microbiology · 2026
    Article
  19. Review
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

Melinda A EngevikDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, Texas; Texas Children's Microbiome Center, Department of Pathology, Texas Children's Hospital, Houston, Texas. Electronic address: melinda.engevik@bcm.edu.
Heather A DanhofDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas.
Jennifer AuchtungDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas; Department of Food Science and Technology, University of Nebraska-Lincoln, Lincoln, Nebraska.
Bradley T EndresDepartment of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas.
Wenly RuanDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, Texas; Texas Children's Microbiome Center, Department of Pathology, Texas Children's Hospital, Houston, Texas.
Eugénie BassèresDepartment of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas.
Amy C EngevikDepartment of Surgical Sciences, Vanderbilt University Medical Center, Nashville, Tennessee.
Qinglong WuDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, Texas; Texas Children's Microbiome Center, Department of Pathology, Texas Children's Hospital, Houston, Texas.
Maribeth NicholsonDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
Ruth Ann LunaDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, Texas; Texas Children's Microbiome Center, Department of Pathology, Texas Children's Hospital, Houston, Texas.
Kevin W GareyDepartment of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas.
Sue E CrawfordDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas.
Mary K EstesDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas; Department of Surgical Sciences, Vanderbilt University Medical Center, Nashville, Tennessee.
Renate LuxDepartment of Periodontics, University of California Los Angeles School of Dentistry, Los Angeles, California.
Mary Beth YacyshynDepartment of Medicine Division of Digestive Diseases University of Cincinnati College of Medicine, Cincinnati, Ohio.
Bruce YacyshynDepartment of Medicine Division of Digestive Diseases University of Cincinnati College of Medicine, Cincinnati, Ohio.
Tor SavidgeDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, Texas; Texas Children's Microbiome Center, Department of Pathology, Texas Children's Hospital, Houston, Texas.
Robert A BrittonDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas.
James VersalovicDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, Texas; Texas Children's Microbiome Center, Department of Pathology, Texas Children's Hospital, Houston, Texas.
Baylor College of Medicine · USUniversity of Houston · USUniversity of Cincinnati Medical Center · USVanderbilt University Medical Center · USUniversity of California, Los Angeles · USUniversity of Nebraska–Lincoln · US

Funding

Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Hashem B El-Serag · 2001 to 2026
$28.3M
Proteomics CoreP30DK123704 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DON C. ROCKEY · 2020 to 2026
$8.8M
Decoding Antibiotic-induced Susceptibility to Clostridium difficile InfectionU01AI124290 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BRITTON, ROBERT A, GAREY, KEVIN W · 2016 to 2020
$7.9M
Diet driven evolution of epidemic ribotypes of Clostridium difficileR01AI123278 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BRITTON, ROBERT A · 2018 to 2022
$2.0M
Identifying the role of serotonin receptor 4 and trefoil factor 3 in intestinal wound repairK01DK123195 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ENGEVIK, MELINDA ANNE · 2020 to 2024
$612k
Metabolic adaptation drives pathogenicity of C. difficile epidemic strain RT078F32AI136404 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI DANHOF, HEATHER A. · 2019 to 2021
$191k
NIAID NIH HHS F32 AI136404NIAID NIH HHS R01 AI123278NIAID NIH HHS U01 AI124290NIDDK NIH HHS K01 DK123195NIDDK NIH HHS P30 DK056338NIDDK NIH HHS P30 DK123704
6 · The paper itself

Abstract

BACKGROUND &

aimsAlthough Clostridioides difficile infection (CDI) is known to involve the disruption of the gut microbiota, little is understood regarding how mucus-associated microbes interact with C difficile. We hypothesized that select mucus-associated bacteria would promote C difficile colonization and biofilm formation.

methodsTo create a model of the human intestinal mucus layer and gut microbiota, we used bioreactors inoculated with healthy human feces, treated with clindamycin and infected with C difficile with the addition of human MUC2-coated coverslips.

resultsC difficile was found to colonize and form biofilms on MUC2-coated coverslips, and 16S rRNA sequencing showed a unique biofilm profile with substantial cocolonization with Fusobacterium species. Consistent with our bioreactor data, publicly available data sets and patient stool samples showed that a subset of patients with C difficile infection harbored high levels of Fusobacterium species. We observed colocalization of C difficile and F nucleatum in an aggregation assay using adult patients and stool of pediatric patients with inflammatory bowel disease and in tissue sections of patients with CDI. C difficile strains were found to coaggregate with F nucleatum subspecies in vitro; an effect that was inhibited by blocking or mutating the adhesin RadD on Fusobacterium and removal of flagella on C difficile. Aggregation was shown to be unique between F nucleatum and C difficile, because other gut commensals did not aggregate with C difficile. Addition of F nucleatum also enhanced C difficile biofilm formation and extracellular polysaccharide production.

conclusionsCollectively, these data show a unique interaction of between pathogenic C difficile and F nucleatum in the intestinal mucus layer.

Indexed as

Adhesins, BacterialBacterial AdhesionBiofilmsBioreactorsClostridioides difficileClostridium InfectionsFecesFlagellaFusobacterium nucleatumGastrointestinal MicrobiomeHT29 CellsHumansIntestinal MucosaMucin-2Adhesins, BacterialMUC2 protein, humanMucin-2BiofilmClostridioides difficileMUC2Mucus

Identifiers

PMID33227279
PMCPMC7956072
OpenAlexW3099633676

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.